{"entity":{"type":"insider","cik":"0001487767","url":"/insider/0001487767","json_url":"/insider/0001487767.json","name":"Aberman Michael S","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":72,"n_filings":13,"first":"2011-09-07","last":"2017-06-23","span_basis":"filed_date"},"name_variants":[{"name":"Aberman Michael S","source":"filing","n_filings":13,"first_seen":"2011-09-07","last_seen":"2017-06-23"}],"transactions":[{"id":4155169,"accession":"0001708138-17-000011","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001708138-17-000011","line_url":"/filing/0001708138-17-000011","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001487767","owner_name":"Aberman Michael S","owner_display_name":"Aberman Michael S","owner_url":"/insider/0001487767","role":"Officer (SVP Strategy Investor Relation)","role_mark":"O","role_mark_label":"Officer (SVP Strategy Investor Relation)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Strategy Investor Relation","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2269.0,"shares_display":"2,269","price_per_share":532.4198721903922,"price_display":"532.42","price_state":"stated","total_value":1208060.69,"total_display":"1,208,060.69","total_whole":"1,208,061","shares_owned_after":4993.0,"shares_owned_after_display":"4,993","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-22","filed_date":"2017-06-23","scope":"insider","n_lines":12},{"id":8217610,"accession":"0001237899-15-000027","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001237899-15-000027","line_url":"/filing/0001237899-15-000027","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001487767","owner_name":"Aberman Michael S","owner_display_name":"Aberman Michael S","owner_url":"/insider/0001487767","role":"Officer (SVP Strategy Investor Relation)","role_mark":"O","role_mark_label":"Officer (SVP Strategy Investor Relation)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Strategy Investor Relation","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4843.0,"shares_display":"4,843","price_per_share":478.98783192236215,"price_display":"478.99","price_state":"stated","total_value":2319738.07,"total_display":"2,319,738.07","total_whole":"2,319,738","shares_owned_after":12598.0,"shares_owned_after_display":"12,598","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-24","filed_date":"2015-03-25","scope":"insider","n_lines":9},{"id":8505652,"accession":"0001237899-15-000026","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001237899-15-000026","line_url":"/filing/0001237899-15-000026","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001487767","owner_name":"Aberman Michael S","owner_display_name":"Aberman Michael S","owner_url":"/insider/0001487767","role":"Officer (SVP Strategy Investor Relation)","role_mark":"O","role_mark_label":"Officer (SVP Strategy Investor Relation)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Strategy Investor Relation","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3442.0,"shares_display":"3,442","price_per_share":465.00341080767,"price_display":"465.00","price_state":"stated","total_value":1600541.74,"total_display":"1,600,541.74","total_whole":"1,600,542","shares_owned_after":24040.0,"shares_owned_after_display":"24,040","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-18","filed_date":"2015-03-19","scope":"insider","n_lines":9},{"id":8612156,"accession":"0001237899-15-000021","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001237899-15-000021","line_url":"/filing/0001237899-15-000021","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001487767","owner_name":"Aberman Michael S","owner_display_name":"Aberman Michael S","owner_url":"/insider/0001487767","role":"Officer (SVP Strategy Investor Relation)","role_mark":"O","role_mark_label":"Officer (SVP Strategy Investor Relation)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Strategy Investor Relation","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3374.0,"shares_display":"3,374","price_per_share":418.4801096621221,"price_display":"418.48","price_state":"stated","total_value":1411951.89,"total_display":"1,411,951.89","total_whole":"1,411,952","shares_owned_after":19000.0,"shares_owned_after_display":"19,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-24","filed_date":"2015-02-25","scope":"insider","n_lines":5},{"id":8505608,"accession":"0001237899-15-000014","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001237899-15-000014","line_url":"/filing/0001237899-15-000014","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001487767","owner_name":"Aberman Michael S","owner_display_name":"Aberman Michael S","owner_url":"/insider/0001487767","role":"Officer (SVP Strategy Investor Relation)","role_mark":"O","role_mark_label":"Officer (SVP Strategy Investor Relation)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP Strategy Investor Relation","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3692.0,"shares_display":"3,692","price_per_share":404.45980498374865,"price_display":"404.46","price_state":"stated","total_value":1493265.6,"total_display":"1,493,265.60","total_whole":"1,493,266","shares_owned_after":19600.0,"shares_owned_after_display":"19,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-17","filed_date":"2015-02-18","scope":"insider","n_lines":6},{"id":6718838,"accession":"0001237899-14-000060","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001237899-14-000060","line_url":"/filing/0001237899-14-000060#line-4","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001487767","owner_name":"Aberman Michael S","owner_display_name":"Aberman Michael S","owner_url":"/insider/0001487767","role":"Officer (VP Strategy and Investor Relat)","role_mark":"O","role_mark_label":"Officer (VP Strategy and Investor Relat)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Strategy and Investor Relat","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3611.0,"shares_display":"3,611","price_per_share":350.0,"price_display":"350.00","price_state":"stated","total_value":1263850.0,"total_display":"1,263,850.00","total_whole":"1,263,850","shares_owned_after":15600.0,"shares_owned_after_display":"15,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-19","filed_date":"2014-08-19","scope":"insider"},{"id":7057626,"accession":"0001237899-14-000023","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001237899-14-000023","line_url":"/filing/0001237899-14-000023#line-13","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001487767","owner_name":"Aberman Michael S","owner_display_name":"Aberman Michael S","owner_url":"/insider/0001487767","role":"Officer (VP Strategy and Investor Relat)","role_mark":"O","role_mark_label":"Officer (VP Strategy and Investor Relat)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Strategy and Investor Relat","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1100.0,"shares_display":"1,100","price_per_share":332.41,"price_display":"332.41","price_state":"stated","total_value":365651.0,"total_display":"365,651.00","total_whole":"365,651","shares_owned_after":16848.0,"shares_owned_after_display":"16,848","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-18","filed_date":"2014-02-19","scope":"insider"},{"id":7057624,"accession":"0001237899-14-000023","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001237899-14-000023","line_url":"/filing/0001237899-14-000023#line-12","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001487767","owner_name":"Aberman Michael S","owner_display_name":"Aberman Michael S","owner_url":"/insider/0001487767","role":"Officer (VP Strategy and Investor Relat)","role_mark":"O","role_mark_label":"Officer (VP Strategy and Investor Relat)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Strategy and Investor Relat","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":948.0,"shares_display":"948","price_per_share":333.5,"price_display":"333.50","price_state":"stated","total_value":316158.0,"total_display":"316,158.00","total_whole":"316,158","shares_owned_after":15900.0,"shares_owned_after_display":"15,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-18","filed_date":"2014-02-19","scope":"insider"},{"id":7057622,"accession":"0001237899-14-000023","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001237899-14-000023","line_url":"/filing/0001237899-14-000023#line-11","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001487767","owner_name":"Aberman Michael S","owner_display_name":"Aberman Michael S","owner_url":"/insider/0001487767","role":"Officer (VP Strategy and Investor Relat)","role_mark":"O","role_mark_label":"Officer (VP Strategy and Investor Relat)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Strategy and Investor Relat","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":334.24,"price_display":"334.24","price_state":"stated","total_value":100272.0,"total_display":"100,272.00","total_whole":"100,272","shares_owned_after":15600.0,"shares_owned_after_display":"15,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-18","filed_date":"2014-02-19","scope":"insider"},{"id":7057620,"accession":"0001237899-14-000023","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001237899-14-000023","line_url":"/filing/0001237899-14-000023#line-10","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001487767","owner_name":"Aberman Michael S","owner_display_name":"Aberman Michael S","owner_url":"/insider/0001487767","role":"Officer (VP Strategy and Investor Relat)","role_mark":"O","role_mark_label":"Officer (VP Strategy and Investor Relat)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Strategy and Investor Relat","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":327.56,"price_display":"327.56","price_state":"stated","total_value":98268.0,"total_display":"98,268.00","total_whole":"98,268","shares_owned_after":18648.0,"shares_owned_after_display":"18,648","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-18","filed_date":"2014-02-19","scope":"insider"},{"id":7057618,"accession":"0001237899-14-000023","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001237899-14-000023","line_url":"/filing/0001237899-14-000023#line-9","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001487767","owner_name":"Aberman Michael S","owner_display_name":"Aberman Michael S","owner_url":"/insider/0001487767","role":"Officer (VP Strategy and Investor Relat)","role_mark":"O","role_mark_label":"Officer (VP Strategy and Investor Relat)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Strategy and Investor Relat","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":331.16,"price_display":"331.16","price_state":"stated","total_value":66232.0,"total_display":"66,232.00","total_whole":"66,232","shares_owned_after":17948.0,"shares_owned_after_display":"17,948","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-18","filed_date":"2014-02-19","scope":"insider"},{"id":7057616,"accession":"0001237899-14-000023","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001237899-14-000023","line_url":"/filing/0001237899-14-000023#line-8","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001487767","owner_name":"Aberman Michael S","owner_display_name":"Aberman Michael S","owner_url":"/insider/0001487767","role":"Officer (VP Strategy and Investor Relat)","role_mark":"O","role_mark_label":"Officer (VP Strategy and Investor Relat)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Strategy and Investor Relat","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":330.87,"price_display":"330.87","price_state":"stated","total_value":66174.0,"total_display":"66,174.00","total_whole":"66,174","shares_owned_after":18148.0,"shares_owned_after_display":"18,148","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-18","filed_date":"2014-02-19","scope":"insider"},{"id":7057615,"accession":"0001237899-14-000023","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001237899-14-000023","line_url":"/filing/0001237899-14-000023#line-7","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001487767","owner_name":"Aberman Michael S","owner_display_name":"Aberman Michael S","owner_url":"/insider/0001487767","role":"Officer (VP Strategy and Investor Relat)","role_mark":"O","role_mark_label":"Officer (VP Strategy and Investor Relat)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Strategy and Investor Relat","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":329.34,"price_display":"329.34","price_state":"stated","total_value":65868.0,"total_display":"65,868.00","total_whole":"65,868","shares_owned_after":18348.0,"shares_owned_after_display":"18,348","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-18","filed_date":"2014-02-19","scope":"insider"},{"id":7057613,"accession":"0001237899-14-000023","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001237899-14-000023","line_url":"/filing/0001237899-14-000023#line-6","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001487767","owner_name":"Aberman Michael S","owner_display_name":"Aberman Michael S","owner_url":"/insider/0001487767","role":"Officer (VP Strategy and Investor Relat)","role_mark":"O","role_mark_label":"Officer (VP Strategy and Investor Relat)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Strategy and Investor Relat","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":325.36,"price_display":"325.36","price_state":"stated","total_value":65072.0,"total_display":"65,072.00","total_whole":"65,072","shares_owned_after":18948.0,"shares_owned_after_display":"18,948","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-18","filed_date":"2014-02-19","scope":"insider"}],"collapsed":true,"next_cursor":"2014-02-18|7057613","ledger_fault":false,"count":{"value":72,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":72,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":72},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000872589","name":"REGENERON PHARMACEUTICALS INC","url":"/issuer/0000872589","role":"Officer (SVP Strategy Investor Relation)","n_filings":13,"first_seen":"2011-09-07","last_seen":"2017-06-23"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001487767","retrieved_at":"2026-08-26T06:36:09+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}